CRISCuris, Inc.

$15M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+8.4% YoY

Gross Profit

$3M99.5% margin

Operating Income

-$7M-218.0% margin

Net Income

-$8M-243.4% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+15.5%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$924,000

Balance Sheet

Total Assets

$28M

Total Liabilities

$42M

Stockholders' Equity

-$15M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+8.4%
Gross Profit	$3M	$3M	+8.7%
Operating Income	-$7M	-$11M	+34.5%
Net Income	-$8M	-$10M	+23.4%

Revenue Segments

Reportable Segment

$3M100%

CRIS Q3 2025 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena